Rosiglitazone

tumor necrosis factor ; Rattus norvegicus







40 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31957860 Effect of rosiglitazone on myocardial injury in septic rats through NF-κB pathway. 2020 Jan 3
2 32606592 Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model. 2020 1
3 32876675 Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production. 2020 Nov 16 6
4 33339154 Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes. 2020 Dec 16 1
5 30682409 Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats. 2019 Jun 1
6 31493866 Inhibition of perivascular mast cell activation is involved in the atheroprotective effect of rosiglitazone in apolipoprotein E-deficient mice. 2019 Nov 5 1
7 29730170 The antidepressant effects of rosiglitazone on rats with depression induced by neuropathic pain. 2018 Jun 15 1
8 28291540 Roux-en-Y gastric bypass improves glucose homeostasis, reduces oxidative stress and inflammation in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway. 2017 Jul 1
9 26394869 Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway. 2016 Jan 1
10 26947332 Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats. 2016 Apr 15 1
11 26178497 [Effects of rosiglitazone on levels of TNFα in septic rats with acute kidney injury]. 2015 May 19 4
12 24839089 Effects of PPAR-γ agonist treatment on LPS-induced mastitis in rats. 2014 Dec 2
13 25399210 Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy? 2014 Nov 1
14 23569141 Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury. 2013 Feb 1
15 23783408 Effect of angiopoietin-like protein 4 on rat pulmonary microvascular endothelial cells exposed to LPS. 2013 Sep 1
16 24001946 Disparity in actions of rosiglitazone against cisplatin-induced nephrotoxicity in female Sprague-Dawley rats. 2013 Nov 1
17 20382448 Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. 2012 Jan 1
18 22842585 Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. 2012 Sep 18 1
19 23125852 Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis. 2012 3
20 20034949 Rosiglitazone ameliorates endotoxin-induced organ damage in conscious rats. 2011 Jan 2
21 20965162 The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. 2011 Jan 10 2
22 21893696 Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats. 2011 Jun 1
23 21959602 Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats. 2011 Oct 2
24 22219595 Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice. 2011 Dec 28 1
25 21224499 Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats. 2010 Dec 2
26 19237016 Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. 2009 Feb 1
27 19356226 Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats. 2009 Apr 8 1
28 19527823 Neferine enhances insulin sensitivity in insulin resistant rats. 2009 Jul 6 1
29 27990201 Role of Rosiglitazone as a Gastroprotective Agent Against Indomethacin-Induced Gastric Mucosal Injury in Rats. 2009 Dec 1
30 18455351 Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats. 2008 Aug 1
31 18479673 Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. 2008 Jun 18 1
32 16770837 Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells. 2007 Feb 2
33 17594812 [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis]. 2007 Jun 1
34 16796890 [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats]. 2006 May 16 2
35 15665514 The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alpha-induced IL-6 secretion in ventricular myocytes. 2005 4
36 15876425 Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. 2005 Jun 15 1
37 16157299 Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. 2005 Oct 28 2
38 16307220 Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. 2005 Nov 1
39 15365619 Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42/p44 mitogen-activated protein kinases. 2004 Sep 3
40 9931102 TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. 1999 Jan 2